Sort
15,842 grants matching “pancreatic cancer”
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$386,069Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · CA
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
$386,010Rebekah White · University Of California, San Diego · R01 · FY2022 · CA
Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation
$386,000Livia Schiavinato Eberlin · University Of Texas At Austin · R33 · FY2020 · CA
Targeting the liver for immunotherapy in pancreatic cancer
$385,938Gregory L Beatty · University Of Pennsylvania · R01 · FY2022 · CA
Targeting the liver for immunotherapy in pancreatic cancer
$385,938Gregory L Beatty · University Of Pennsylvania · R01 · FY2025 · CA
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$385,902Minah Kim · Columbia University Health Sciences · R37 · FY2022 · CA
Mechanochemical Effects on Tumor Cell Signaling, Adhersion and Migration
$385,874Konstantinos Konstantopoulos · Johns Hopkins University · U54 · FY2012 · CA
Targeting tumor and its microenvironment using nanotherapeutics for pancreatic cancer
$385,840Satyanarayana Rachagani · University Of Nebraska Medical Center · R01 · FY2020 · CA
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
$385,801Daniel L Marks · Oregon Health & Science University · R01 · FY2022 · CA
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
$385,801Teresa A Zimmers · Oregon Health & Science University · R01 · FY2023 · CA
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$385,747Kenneth P Olive · Columbia University Health Sciences · R01 · FY2014 · CA
Key factors in human ribosome biogenesis
$385,743Susan J Baserga · Yale University · R01 · FY2015 · GM
EGF and TGF-β signaling synergy in β-cell proliferation
$385,625George K. Gittes · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · DK
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$385,147Kenneth P Olive · Columbia University Health Sciences · R01 · FY2020 · CA
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$385,147Kenneth P Olive · Columbia University Health Sciences · R01 · FY2021 · CA
Development of (R,S')-MNF as a dual-targeted therapy for pancreatic cancer
$385,139Irving Wainer · Paz Pharmaceuticals · R41 · FY2022 · CA
Studying the initiation, progression and therapy of lung cancer in mouse models
$385,000Martin McMahon · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Transcriptional regulation of pluripotency in the early vertebrate embryo
$385,000Daniel Weinstein · Queens College · R15 · FY2017 · GM
Mutant p53 as actionable cancer-specific target
$384,974Ute M Moll · State University New York Stony Brook · R01 · FY2019 · CA
Molecular Mechanisms of Acute Pancreatitis
$384,846Craig D Logsdon · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · DK
Regulation of p53 acetylation and deacetylation in tumorigenesis.
$384,750Wei Gu · Columbia University Health Sciences · R01 · FY2021 · CA
Regulation of p53 acetylation and deacetylation in tumorigenesis.
$384,750Wei Gu · Columbia University Health Sciences · R01 · FY2020 · CA
Integration of neo-antigen vaccines and immune checkpoint therapy
$384,650Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA
Structure and Mechanism of Transcription Factors in Pancreatic Beta Cells
$384,606Scott A Showalter · Pennsylvania State University, The · R01 · FY2019 · DK
Studying the initiation, progression and therapy of lung cancer in mouse models
$384,375Martin McMahon · University Of Utah · R01 · FY2023 · CA